NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 5.17% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 5.02% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.52% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.45% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.08% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.85% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.64% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | null | null | 2.50% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 2.40% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.36% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.16% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| RGEN | Repligen Corporation | Healthcare | Medical Instruments & Supplies | 1.96% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 1.90% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.88% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.87% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.86% |